5.7 (0.49%)
0.35 (0.03%) 1.15 pm | 02 Nov 2011 | Source: CNBC-TV18
Speaking to CNBC-TV18, Kewal Handa, managing director of Pfizer said, the draft NPPP has a few positives but the government needs to re-look at it alt...
9.00 pm | 11 Oct 2011 | Source: CNBC-TV18
The Arun Maira committee report on pharma FDI was accepted by the government which said the CCI should be entrusted with the task of scrutinising phar...
9.10 pm | 30 Aug 2011 | Source: PTI
Domestic biotech industry crossed the USD 4 billion-mark last fiscal, growing from around USD 3 billion in the previous fiscal, according to an Ernst ...
10.22 pm | 01 Aug 2011 | Source: PTI
In an interim relief to pharma firm Pfizer Products, the Delhi High Court restrained Seeko Biotics from making and selling food supplement 'Bitasils',...
8.25 pm | 19 Jul 2011 | Source: PTI
Pfizer, the Indian unit of drug maker Pfizer Inc, is eyeing a 13-14% growth in its revenues in the financial year 2011-12, a senior company official s...
11.13 am | 11 Jul 2011 | Source: CNBC-TV18
Rural markets are hot and ripen. While many experts feel that the rural markets are where the pot of gold is FMCG companies have already launched prod...
6.52 pm | 01 Jul 2011 | Source: PTI
With India emerging as a major clinical research destination, the Rs 8,000-crore industry is likely to generate 50,000 jobs in next five years, indust...
12.58 pm | 02 May 2011 | Source: CNBC-TV18
Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an excl...
1.05 pm | 21 Mar 2011 | Source: CNBC-TV18
The US Foods and Drugs Administration (USFDA) will be sued by the US pharmaceutical company Mylan Inc, for an injunction on the launch of Ranbaxy’s ch...
4.31 pm | 11 Jan 2011 | Source: Moneycontrol.com
Pfizer at its meeting held on January 11, 2011 has declared interim dividend at Rs 12.50 per share of Rs 10 each i:e 125%....
11.13 am | 07 Jan 2011 | Source: Moneycontrol.com
Pfizer has its Board of Directors meeting on January 11, 2011 to consider interim dividend....
10.59 am | 03 Jan 2011 | Source: CNBC-TV18
In an exclusive interview with CNBC-TV 18, Kiran Mazumdar Shaw, CMD of Biocon says that Clingene & Syngene to undergo transformation in the business ...